NDC 72162-2597-01 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2597
- Requested NDC
- 72162-2597-01
- Package NDCs from labels
- 72162-2597-1, 72162-2597-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-01-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2597-1 | GLYCOPYRROLATE | 100 in 1 BOTTLE | Tablet | 100 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2597-1 | EA - Each | 72162-2597 | 0c3eb861-de19-43eb-b928-619b53fedcf0 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 250eeef7-b1a9-45e7-a927-7807232e10be | 2023-09-22 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 54458620-d888-4df6-ae4b-78c3dfed3423 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 88d3e865-8dca-4c89-b6f7-a34c481f75b9 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 4c733750-45fe-4876-8e4f-c61c52470405 | 2023-06-06 | Warnings, Adverse reactions | 197739 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 86abf577-562c-5eb1-e053-2a91aa0ac10f | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 66726c2b-27e8-5dd1-e053-2991aa0a1ba7 | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 69353cc1-f5d4-170b-e053-2a91aa0ad5a5 | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 6934f467-949f-97cc-e053-2a91aa0a05fb | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 95fbe384-eaff-1f2e-e053-2a95a90a0313 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9e5113b7-1c0c-24bd-e053-2995a90ab94b | 2023-05-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | bbf0abe2-8deb-19b2-e053-2a95a90a60a3 | 2023-05-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | b622f21f-fa37-1259-e053-2995a90aa796 | 2023-05-04 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | a2a2a03f-21cc-5fec-e053-2995a90a84cb | 2023-05-03 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | LGM PHARMA SOLUTIONS, LLC | 392a969d-1e14-4ad8-835c-a47be4983067 | 2023-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | e8bb95ed-09f1-fcf1-e053-2a95a90a93e5 | 2023-04-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | ea4c8be4-a1e9-5901-e053-2995a90a5e63 | 2023-04-24 | Warnings, Adverse reactions | V92SO9WP2I |
| BEVESPI AEROSPHERE | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | ae02436e-9528-490e-a844-0c0f6f2843f9 | 2023-03-24 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.